Does the shingles jab slash your risk of dementia? Drugs giant GSK launches ground-breaking study that could save millions of Brits from developing the disease
The trailblazing study will use the data from up to 1.4million NHS patients to test whether its shingles vaccine reduces the ...
Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
GSK pushes UK government to give more access to health data, Bloomberg says
GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...
GSK Wants UK to Open Up Health Records to Boost Drug Development
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...
World Business Council for Sustainable Development (WBCSD)2d
WBCSD and pharmaceutical companies release first sector Roadmap towards nature-positive action
The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and supported by PwC UK, has published the Roadmap to Nature Positive: ...
Pharmabiz3d
GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative
GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative: London, UK Thursday, March 27, 2025, 09:00 Hrs [I ...
Pharmaceutical Technology on MSN4d
GSK and UK researchers plan to study Shingrix and dementia risk reduction link
The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
GSK, UK DRI, HDR UK to collaborate on dementia research initiative
GSK (GSK) plc announced a new research collaboration with the UK Dementia Research Institute and Health Data Research UK to advance ...
BioSpace4d
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...